Numbers and rates* of deaths with Hepatitis B virus infections listed as a cause of death† among residents, by demographic characteristics — United States, 2017–2021
Characteristics | 2017 No. | 2017 Rate* (95% CI) |
2018 No. | 2018 Rate* (95% CI) |
2019 No. | 2019 Rate* (95% CI) |
2020 No. | 2020 Rate* (95% CI) |
2021 No. | 2021 Rate* (95% CI) |
---|---|---|---|---|---|---|---|---|---|---|
Total | 1,727 | 0.46 (0.44–0.49) |
1,649 | 0.43 (0.41–0.45) |
1,662 | 0.42 (0.40–0.44) |
1,752 | 0.45 (0.42–0.47) |
1,748 | 0.44 (0.42–0.46) |
Age (Years) | ||||||||||
0–34 | 29 | 0.02 (0.01–0.03) |
32 | 0.02 (0.01–0.03) |
45 | 0.03 (0.02–0.04) |
36 | 0.02 (0.02–0.03) |
30 | 0.02 (0.01–0.03) |
35–44 | 106 | 0.26 (0.21–0.31) |
122 | 0.30 (0.24–0.35) |
110 | 0.26 (0.21–0.31) |
109 | 0.26 (0.21–0.31) |
123 | 0.28 (0.23–0.33) |
45–54 | 323 | 0.76 (0.68–0.85) |
283 | 0.68 (0.60–0.76) |
255 | 0.62 (0.55–0.70) |
269 | 0.67 (0.59–0.75) |
265 | 0.65 (0.57–0.73) |
55–64 | 548 | 1.30 (1.20–1.41) |
520 | 1.23 (1.12–1.34) |
502 | 1.18 (1.08–1.29) |
483 | 1.14 (1.04–1.24) |
486 | 1.14 (1.03–1.24) |
65–74 | 417 | 1.40 (1.27–1.54) |
422 | 1.38 (1.25–1.52) |
484 | 1.54 (1.40–1.67) |
495 | 1.52 (1.39–1.65) |
513 | 1.52 (1.39–1.66) |
≥75 | 303 | 1.43 (1.27–1.59) |
270 | 1.23 (1.08–1.38) |
266 | 1.18 (1.04–1.32) |
360 | 1.56 (1.40–1.72) |
331 | 1.49 (1.33–1.65) |
Sex | ||||||||||
Male | 1,275 | 0.70 (0.66–0.74) |
1,191 | 0.65 (0.61–0.69) |
1,248 | 0.66 (0.62–0.70) |
1,278 | 0.66 (0.63–0.70) |
1,260 | 0.65 (0.61–0.68) |
Female | 452 | 0.23 (0.20–0.25) |
458 | 0.22 (0.20–0.24) |
414 | 0.21 (0.19–0.24) |
474 | 0.22 (0.20–0.24) |
488 | 0.22 (0.20–0.24) |
Race/Ethnicity | ||||||||||
White, non-Hispanic | 776 | 0.28 (0.26–0.30) |
754 | 0.27 (0.25–0.29) |
757 | 0.28 (0.26–0.30) |
739 | 0.27 (0.25–0.29) |
702 | 0.26 (0.24–0.28) |
Black, non-Hispanic | 320 | 0.74 (0.66–0.83) |
303 | 0.72 (0.63–0.80) |
290 | 0.67 (0.59–0.75) |
307 | 0.69 (0.61–0.77) |
306 | 0.66 (0.59–0.74) |
Hispanic | 109 | 0.26 (0.21–0.32) |
122 | 0.28 (0.23–0.33) |
117 | 0.27 (0.21–0.32) |
132 | 0.28 (0.23–0.33) |
136 | 0.28 (0.23–0.32) |
Asian/Pacific Islander, non-Hispanic | 492 | 2.45 (2.23–2.67) |
434 | 2.14 (1.94–2.35) |
457 | 2.13 (1.92–2.32) |
537 | 2.51 (2.30–2.73) |
564 | 2.54 (2.33–2.76) |
Asian, non-Hispanic | n/a | n/a | 417 | 2.13 (1.92–2.32) |
439 | 2.12 (1.92–2.32) |
514 | 2.48 (2.26–2.70) |
528 | 2.43 (2.22–2.64) |
Native Hawaiian or Other Pacific Islander, non-Hispanic | n/a | n/a | 17 | UR | 18 | UR | 23 | 3.89 (2.44–.89) |
36 | 5.95 (4.12–8.31) |
American Indian/Alaska Native, non-Hispanic | 17 | UR | S | UR | 16 | UR | 16 | UR | 16 | UR |
Multiple race, non-Hispanic | n/a | n/a | 12 | UR | 15 | UR | 12 | UR | 14 | UR |
HHS Region: Regional Office ¶ | ||||||||||
Region 1: Boston | 60 | 0.35 (0.27–0.46) |
64 | 0.34 (0.26–0.45) |
43 | 0.22 (0.16–0.30) |
49 | 0.24 (0.18–0.33) |
58 | 0.28 (0.21–0.37) |
Region 2: New York | 166 | 0.47 (0.39–0.54) |
156 | 0.44 (0.36–0.51) |
147 | 0.42 (0.35–0.49) |
154 | 0.43 (0.36–0.50) |
149 | 0.41 (0.34–0.48) |
Region 3: Philadelphia | 128 | 0.32 (0.27–0.38) |
130 | 0.35 (0.29–0.41) |
126 | 0.32 (0.26–0.38) |
135 | 0.35 (0.29–0.41) |
130 | 0.34 (0.28–0.40) |
Region 4: Atlanta | 365 | 0.45 (0.41–0.50) |
346 | 0.45 (0.40–0.50) |
348 | 0.42 (0.38–0.47) |
352 | 0.43 (0.39–0.48) |
338 | 0.42 (0.37–0.47) |
Region 5: Chicago | 184 | 0.29 (0.24–0.33) |
174 | 0.28 (0.24–0.33) |
173 | 0.27 (0.23–0.31) |
212 | 0.33 (0.29–0.38) |
217 | 0.33 (0.28–0.37) |
Region 6: Dallas | 247 | 0.55 (0.48–0.62) |
230 | 0.47 (0.41–0.53) |
230 | 0.48 (0.42–0.55) |
229 | 0.47 (0.40–0.53) |
261 | 0.53 (0.46–0.59) |
Region 7: Kansas City | 50 | 0.29 (0.22–0.39) |
65 | 0.38 (0.29–0.48) |
51 | 0.30 (0.22–0.40) |
51 | 0.32 (0.23–0.42) |
35 | 0.21 (0.15–0.30) |
Region 8: Denver | 48 | 0.37 (0.27–0.49) |
34 | 0.25 (0.17–0.35) |
47 | 0.32 (0.23–0.43) |
54 | 0.41 (0.31–0.54) |
48 | 0.34 (0.25–0.45) |
Region 9: San Francisco | 393 | 0.69 (0.62–0.76) |
369 | 0.62 (0.56–0.69) |
394 | 0.64 (0.57–0.70) |
411 | 0.66 (0.59–0.72) |
408 | 0.68 (0.61–0.74) |
Region 10: Seattle | 86 | 0.52 (0.41–0.64) |
81 | 0.47 (0.37–0.59) |
103 | 0.58 (0.47–0.70) |
105 | 0.60 (0.48–0.72) |
104 | 0.61 (0.49–0.73) |
* Rates for race/ethnicity, sex, US Department of Health and Human Services region, and the overall total are age-adjusted per 100,000 US standard population during 2000 by using the following age group distribution (in years): <1, 1–4, 5–14, 15–24, 25–34, 35–44, 45–54, 55–64, 65–74, 75–84, and ≥85. For age-adjusted death rates, the age-specific death rate is rounded to one decimal place before proceeding to the next step in the calculation of age-adjusted death rates for NCHS Multiple Cause of Death on CDC WONDER. This rounding step might affect the precision of rates calculated for small numbers of deaths. Missing data are not included.
§ The bridged-race categories were used for 2017 while single-race categories were used during 2018–2021. Single-race and bridged-race categories are not directly comparable (see Technical Notes).
¶ US Department of Health and Human Services regions were categorized according to the grouping of states and US territories assigned under each of the 10 Health and Human Services regional offices. For the purposes of this report, regions with US territories (Regions 2 and 9) contain data from states only.
n/a: Not applicable. This race category was not available for 2017 data.
UR: Unreliable rate. Rates where death counts were less than 20 were not displayed because of the instability associated with those rates.
S: Suppressed. In order to prevent revealing information that may identify specific individuals, small data values are not available when the count falls below a ratio of the representative demographic population.
This table summarizes the characteristics of hepatitis B-associated deaths among residents in the United States. During 2021, a total of 1,748 hepatitis B-associated deaths among US residents were reported in the US Multiple Cause of Death data from the National Center for Health Statistics, which corresponds to an age-adjusted death rate of 0.44 cases per 100,000 population.
The US age-adjusted death rates for hepatitis B have been relatively consistent during the five-year period from 2017–2021. In 2021, the mortality rate was highest among non-Hispanic Asian/Pacific Islander persons (2.54 deaths per 100,000 population), almost 10 times the rate among non-Hispanic White persons (0.26 deaths per 100,000 population). Due to changes in the type of race and ethnicity data available from the National Vital Statistics System (NVSS) (see Technical Notes), for the first time, data for hepatitis B-associated deaths is reported separately for non-Hispanic Asian persons with a rate of 2.43 deaths per 100,000 population, and for non-Hispanic Native Hawaiian or Other Pacific Islander persons with a rate of 5.95 deaths per 100,000 persons almost 23 times the rate among non-Hispanic White persons. Variations of disease rates by race or ethnicity may reflect systemic cultural, behavioral, environmental, and social factors, including structural racism.
Hepatitis B-associated mortality rates were also higher among persons aged 55 years and older, males, and in US Department of Health and Human Services Regions 9 (Arizona, California, Hawaii, and Nevada) and 10 (Alaska, Idaho, Oregon, and Washington).
- Figure 2.1. Number of reported cases of acute hepatitis B virus infection and estimated infections — United States, 2014–2021
- Figure 2.2. Rates of reported acute hepatitis B virus infection, by state or jurisdiction — United States, 2020–2021
- Figure 2.3. Rates of reported cases of acute hepatitis B virus infection, by state or jurisdiction — United States, 2021
- Figure 2.4. Rates of reported cases of acute hepatitis B virus infection, by age group — United States, 2006–2021
- Figure 2.5. Rates of reported cases of acute hepatitis B virus infection, by sex — United States, 2006–2021
- Figure 2.6. Rates of reported cases of acute hepatitis B virus infection, by race/ethnicity — United States, 2006–2021
- Figure 2.7. Availability of information on risk behaviors or exposures associated with reported cases of acute hepatitis B virus infection — United States, 2021
- Figure 2.8. Rates of deaths with hepatitis B virus infection listed as a cause of death among residents, by state or jurisdiction — United States, 2021
- Table 2.1. Numbers and rates of reported cases of acute hepatitis B virus infection, by state or jurisdiction — United States, 2017–2021
- Table 2.2. Numbers and rates of reported cases of acute hepatitis B virus infection, by demographic characteristics — United States, 2017–2021
- Table 2.3. Reported risk behaviors or exposures among reported cases of acute hepatitis B virus infection — United States, 2021
- Table 2.4. Number of newly reported cases of perinatal hepatitis B virus infection, by state or jurisdiction — United States, 2021
- Table 2.5. Number and rate of newly reported cases of chronic hepatitis B virus infection, by state or jurisdiction — United States, 2021
- Table 2.6. Number and rate of newly reported cases of chronic hepatitis B virus infection, by demographic characteristics — United States, 2021
- Table 2.7. Numbers and rates of deaths with hepatitis B virus infection listed as a cause of death among residents, by state or jurisdiction — United States, 2017–2021
- Table 2.8. Numbers and rates of deaths with hepatitis B virus infections listed as a cause of death among residents, by demographic characteristics — United States, 2017–2021